Home » Topics » Regulatory

Regulatory
RSS

FDA approves Unituxin for pediatric patients with high-risk neuroblastoma

March 11, 2015

FDA approves Cresemba for invasive aspergillosis and invasive mucormycosis

March 9, 2015

FDA approves Opdivo for metastatic squamous NSCLC

March 5, 2015

Prevenar 13 approved in E.U. for prevention of pneumococcal pneumonia in adults

March 4, 2015

FDA approves Avycaz for cIAI and cUTI

Feb. 26, 2015

FDA approves Novartis's panobinostat for multiple myeloma

Feb. 24, 2015

FDA approves Dymista for use in children with seasonal allergic rhinitis

Feb. 24, 2015

First stem cell-based medicinal product approved in Europe

Feb. 23, 2015

FDA approves sNDA for rufinamide in Lennox-Gastaut syndrome in children aged 1-4 years

Feb. 16, 2015

FDA approves lenvatinib for thyroid cancer

Feb. 16, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...